Keyword Connections

lbh589

Journals

2

1 chemical society reviews

2 cancer

Research Groups

0

No Research Group Connected

Bibliographies

5

1 Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small-cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).

2 Recent advances in circularly polarized electroluminescence based on organic light-emitting diodes.

3 The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties.

4 Transition-metal-catalyzed reactions involving reductive elimination between dative ligands and covalent ligands.

5 Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells.